0 Replies
NOTE: hsa-miR-29c* mentioned in the following paper is the retired name for what is now hsa-miR-29c-5p: http://www.mirbase.org/cgi-bin/mature.pl?mature_acc=MIMAT0004673
PHILADELPHIA and REHOVOT, Israel, Feb. 7, 2013 /PRNewswire/ — Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a study demonstrating the ability of... Contine Reading & Discuss→
0 Replies
James Watson, co-discoverer of the structure of DNA, says anti-metastatic RNAi is the key to beating cancer.
Sending more government cancer monies towards innovative, anti-metastatic drug development to appropriate high-quality academic institutions would better use National Cancer Institute's (NCI) monies than the large sums spent now testing drugs for which…‘The... Contine Reading & Discuss→
0 Replies
PHILADELPHIA and REHOVOT, Israel, Jan. 9, 2013 /PRNewswire/ — Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that data from a study assessing the differences between cancer of unknown primary (CUP) and metastatic solid tumors of known primary metastases (KPM) by profiling... Contine Reading & Discuss→
0 Replies
Medicare-Covered Assay Accurately Identifies Tumor of Origin in Cancer of Unknown Primary
PHILADELPHIA, REHOVOT, Israel, and PITTSBURGH, Oct. 2, 2012 /PRNewswire/ — Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, and Precision Therapeutics, Inc. (PTI), a life science company known for its expertise in... Contine Reading & Discuss→
0 Replies
The miREC database (miRNAs involved in Endometrial Cancer) combines published data about miRNAs and genes deregulated in endometrial cancer, as well as target-regulator relationships between these genes and miRNAs. All information has been extracted from published literature and entries are supplemented by reference citations.
The miREC database was launched in... Contine Reading & Discuss→
0 Replies
Very last minute – but if you are near London and don’t have any plans for Wednesday this might be right event for you:
The third international symposium on Cancer, microRNAs and other non-coding RNAs will highlight the function and regulation of non-coding RNAs during oncogenesis. The symposium will cover... Contine Reading & Discuss→
0 Replies
Title: Recent Work & Current Methods in Cancer microRNA Research – The 2nd in a series of microRNA Webinars presented by LC Sciences
Date: Wed 7/11/12
Please register for the webinar by selecting the presentation time that is most convenient for your timezone.
North America – 1:00 Central Daylight Time... Contine Reading & Discuss→
0 Replies
Date and Location:
January 20—25, 2013
Fairmont Hotel Vancouver, Vancouver, British Columbia, Canada
Meeting Summary:
A recurrent principle in cancer biology is the co-option of pathways that function during development to promote aberrant tumor cell behavior. This principle clearly applies to the roles of noncoding RNAs in cancer. Examples of... Contine Reading & Discuss→
0 Replies
OncomiRs is a new open access journal from Emerging Science Journal program, launched recently by Versita.
The journal will publish original research articles and reviews covering all the basics aspects of the microRNAs implication in tumor formation and development as well as their role in the treatment sensitivity and resistance.... Contine Reading & Discuss→
